Integra LifeSciences Holdings Corporation (IART) vs First Tracks Biotherapeutics Inc (TRAX)

A side-by-side comparison of Integra LifeSciences Holdings Corporation and First Tracks Biotherapeutics Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Integra LifeSciences Holdings Corporation logo
IART
Integra LifeSciences Holdings Corporation
$1.04B
$13.34HealthcareDelayed quote: Oct 6, 2026, 2:05 PM EDT
First Tracks Biotherapeutics Inc logo
TRAX
First Tracks Biotherapeutics Inc
$1.11B
$31.94HealthcareDelayed quote: Oct 6, 2026, 2:05 PM EDT

Total return — IART vs TRAX

growth of $100 · dividends reinvested · last 1y
IART +41.1% (+41.1%/yr)TRAX +73.6% (+73.6%/yr)TRAX compounded faster over this window
100150200250Start $100$141$174
IART TRAX

IART vs TRAX: by the numbers

  • •TRAX is the larger company ($1.11B vs $1.04B market cap).
  • •Both run net losses; TRAX's is the smaller (0.00% vs -0.44% net margin).

Metrics side by side

Valuation

MetricIARTTRAX
Forward P/E5.47N/A
P/S ratio0.63N/A
P/B ratio0.996.60
EV / EBITDA3.54N/A

Profitability

MetricIARTTRAX
Gross margin53.74%0.00%
Operating margin4.18%0.00%
Net margin-0.44%0.00%
ROE-0.69%-57.77%
ROIC20.01%-59.76%

Growth (annualized)

MetricIARTTRAX
Revenue CAGR (5Y)1.77%N/A
Total return CAGR (5Y)-28.16%N/A

Go deeper

Full IART analysisFull TRAX analysisInteractive comparison tool

Dig into the metrics

Integra LifeSciences ROEFirst Tracks Biotherapeutics ROEIntegra LifeSciences operating marginFirst Tracks Biotherapeutics operating marginIntegra LifeSciences revenue growthFirst Tracks Biotherapeutics revenue growthIntegra LifeSciences free cash flowFirst Tracks Biotherapeutics free cash flow

Integra LifeSciences & First Tracks Biotherapeutics appear in these rankings

Highest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.